参考文献/References:
[1] WALDMAN A D, FRITZ J M, LENARDO M J. A guide to cancer immunotherapy: from T cell basic science to clinical practice [J]. Nature Reviews Immunology, 2020, 20(11): 651-668.
[2] BARBERIO M T, PAWLOWSKA N, DHAWAN M, et al. Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer[J]. Nature Communications, 2020, 11(1): 3584.
[3] BHANDARKAR A R, BHANDARKAR S, VUKSANOVIC D B, et al. Characterizing T-cell dysfunction and exclusion signatures in malignant peripheral nerve sheath tumors reveals susceptibilities to immunotherapy[J]. Journal of Neurooncology, 2023, 164(3): 693-699.
[4] MIRSHARIF E S, CHENARY M R, BOZORGMEHR M, et al. Immunophenotyping characteristics of COVID-19 patients: Peripheral blood CD8+ HLA-DR+ T cells as a biomarker for mortality outcome[J]. Journal of Medical Virology, 2023, 95(1): e28192.
[5] DU Juan, WEI Lirong, LI Guoli, et al. Persistent high percentage of HLA-DR+CD38high CD8+ T cells associated with immune disorder and disease severity of COVID-19[J]. Frontiers in Immunology, 2021, 12: 735125.
[6] GORONZY J J, HU Bin, KIM C, et al. Epigenetics of T cell aging[J].Journal of Leukocyte Biology, 2018, 104(4): 691-699.
[7] BISSET L R, LUNG T L, KAELIN M, et al. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland[J]. European Journal of Haematology, 2004, 72(3): 203-212.
[8] RANE S, HOGAN T, SEDDON B, et al. Age is not just a number: Naive T cells increase their ability to persist in the circulation over time[J]. PLoS Biology, 2018, 16(4): e2003949.
[9] XIA Ying, LIU Aqing, LI Wentao, et al. Reference range of na?ve T and T memory lymphocyte subsets in peripheral blood of healthy adult[J]. Clinical and Experimental Immunology, 2022, 207(2): 208-217.
[10] G?MEZ R O, ARQUEROS C, GALANO C, et al. Effector mechanisms of CD8+ HLA-DR+ T cells in breast cancer patients who respond to neoadjuvant chemotherapy[J]. Cancers, 2021, 13(24): 6167.
[11] 林帝金, 刘纯岳, 方俊粤, 等. 乳腺肿瘤患者外周血中T 淋巴细胞表面活化分子和Tregs 的表达研究[J].现代检验医学杂志, 2018, 33(5):31-34,37. LIN Dijin, LIU Chunyue, FANG Junyue, et al. Expression of T lymphocyte surface activating molecules and tregs in peripheral blood of patients with breast neoplass [J]. Journal of Modern Laboratory Medicine, 2018, 33(5): 31-34,37.
[12] JIN Jun, MU Yunmei, ZHANG Huimin, et al. CISH impairs lysosomal function in activated T cells resulting in mitochondrial DNA release and inflammaging[J]. Nature Aging, 2023, 3(5): 600-616.
[13] WANG Yun, LUO Ying, TANG Guoxing, et al. HLA-DR expression level in CD8+ T cells correlates with the severity of children with acute infectious mononucleosis[J].Frontiers in Immunology, 2021, 12: 753290.
[14] WENG Nanping, AKBAR A N, GORONZY J. CD28- T cells: their role in the age-associated decline of immune function[J]. Trends in Immunology, 2009, 30(7): 306-312.
[15] LI Mingde, YAO Danlin, ZENG Xiangbo, et al. Age related human T cell subset evolution and senescence[J].Immunity & Ageing , 2019, 16: 24.
[16] MALY K, SCHIRMER M. The story of CD4+CD28-T cells revisited: solved or still ongoing?[J]. Journal of Immunology Research, 2015, 2015: 348746.
[17] NANDI M, PAL S, GHOSH S, et al. CD8+CD28- T cells: key cytotoxic players impacting disease pathogenesis in chronic HBV infection[J]. Clinical science (London, England : 1979), 2019, 133(17): 1917-1934.
[18] ZHANG Ti, LIU Xin, ZHAO Yue, et al. Excessive IL-15 promotes cytotoxic CD4+CD28- T cell-mediated renal injury in lupus nephritis[J]. Immunity & Ageing, 2022, 19(1): 50.
[19] DEDEOGLU B, MEIJERS R W, KLEPPER M, et al. Loss of CD28 on peripheral T cells decreases the risk for early acute rejection after kidney transplantation[J]. PLoS One, 2016, 11(3): e0150826.
[20] JIA Zhenghu, REN Zhiyao, YE Dongmei, et al. Immune-ageing evaluation of peripheral T and NK lymphocyte subsets in chinese healthy adults[J]. Phenomics (Cham, Switzerland), 2023, 3(4): 360-374.
[21] TANG Guoxing, YUAN Xu, LUO Ying, et al. Establishing immune scoring model based on combination of the number, function, and phenotype of lymphocytes[J]. Aging, 2020, 12(10): 9328-9343.
[22] GLEICHER N, BARAD D H. Gender as risk factor for autoimmune diseases[J]. Journal of Autoimmunity, 2007, 28(1):1-6.
[23] TAKAHASHI T, IWASAKI A. Sex differences in immune responses[J]. Science (New York, N.Y.), 2021, 371(6527): 347-348.
相似文献/References:
[1]姚亚洲,郑引索.72例老年急性白血病免疫表型分析[J].现代检验医学杂志,2015,30(05):91.[doi:10.3969/j.issn.1671-7414.2015.05.027]
YAO Ya-zhou,ZHENG Yin-suo.Immunophenotype Analysis of 72 Cases of Elderly Acute Leukemia[J].Journal of Modern Laboratory Medicine,2015,30(01):91.[doi:10.3969/j.issn.1671-7414.2015.05.027]
[2]常 玉,刘江鑫,李文生.髓系肉瘤伴T细胞异常表达病例的临床特征、形态学、免疫表型及分子遗传学研究[J].现代检验医学杂志,2022,37(03):11.[doi:10.3969/j.issn.1671-7414.2022.03.003]
CHANG Yu,LIU Jiang-xin,LI Wen-sheng.Clinical, Morphological, Immunophenotypic and Genetic Analysis of Myeloid Sarcoma with Abnormal T-cell Expression[J].Journal of Modern Laboratory Medicine,2022,37(01):11.[doi:10.3969/j.issn.1671-7414.2022.03.003]
[3]周林颖,刘 兴,伍 勇,等.HIV/AIDS 患者并发EBV 和HCMV 感染临床免疫学特征及影响因素分析[J].现代检验医学杂志,2024,39(02):91.[doi:10.3969/j.issn.1671-7414.2024.02.017]
ZHOU Linying,LIU Xing,WU Yong,et al.Clinical Immunological Characteristic and Influencing Factors Analysis of HIV/AIDS Patients Infected with EBV and HCMV[J].Journal of Modern Laboratory Medicine,2024,39(01):91.[doi:10.3969/j.issn.1671-7414.2024.02.017]